发明名称 KLEBSIELLA CAPSULE POLYSACCHARIDE VACCINE
摘要 PURPOSE: To provide a safe and novel immune agent which consists of the pure capsule polysaccharides formed by making the lipopolysaccharide contained therein nontoxic by a treatment with a deacylating agent and is useful for active immunity to a Klebsiella infection. CONSTITUTION: The polyvalent immune pharmaceutical prepn. consisting of a nontoxic serum type specific polysaccharide prepn. Namely, the refined capsule polysaccharide(CPS) derived from the bacteria of Klebsiella species are treated with the deacylating agent, such as potassium hydroxide, by which the nonexothermic immunogenic CPS pharmaceutical prepn. is obtd. The Klebsiella infectious disease may be prevented by using the immunogenic Klebsiella species CPS. The capsule polysaccharides are preferably refined from the clean matter in terms of culture of the Klebsiella cultured in a medium consisting of 1 to 5% pie cases S, F, 0.1 to 1% yeast extract and 1 to 10% maltose. The average mol.wt. of the capsule polysaccharide is preferably 1×10<6> dalton. The vaccine is nonorally medicated in order to increase the serum antibody level to the CPS.
申请公布号 JPH06316533(A) 申请公布日期 1994.11.15
申请号 JP19930300093 申请日期 1993.11.30
申请人 SWISS SHIIRAMU & WAKUCHIN INST & INST FOR THE RES OF INFUEKUTEIASU DEIJIIZU 发明人 SUTANREI JIEI KURAIZU
分类号 A61K39/108;A61P31/04;(IPC1-7):A61K39/108 主分类号 A61K39/108
代理机构 代理人
主权项
地址